Sa1856 Pretransplant Elevated Plasma Fibrinogen Level Increases Risk of Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma

Guo-ying Wang,Gui-hua Chen,Yang,Qi Zhang,Hua Li

DOI: https://doi.org/10.1016/s0016-5085(15)33508-3

IF: 29.4

2015-01-01

Gastroenterology

Abstract:to disparities in stage of disease at presentation and HCC treatment received.Our study aims to evaluate race/ethnicity-specific disparities in stage of disease and treatment received among adults with HCC in the U.S. Methods: Using data from the 2003-2011 Surveillance, Epidemiology, and End Results database, a population-based cancer registry in the U.S., we performed a retrospective cohort study examining race/ethnicity-specific differences in stage of disease at diagnosis and cancer treatment received among adults with HCC.Chi-square methods were used to evaluate group-specific differences in stage of disease and treatment received.Forward step-wise logistic regression methods were utilized to create multivariate logistic regression models to evaluate independent predictors of HCC stage at diagnosis and receipt of HCC treatment.The final multivariate model included age, sex, race/ethnicity, stage of disease, and year of diagnosis.Results: Overall HCC incidence was highest among Asians, which was more than double the incidence among non-Hispanic whites (18.6 vs. 7.0 per 100,000/year, p<0.001).When stratified by HCC stage at diagnosis, similar disparities were seen, with the highest incidence seen among Asians for both localized and advanced HCC.From 2003 to 2011, the proportion of patients with HCC diagnosed at a localized stage increased for all groups.However, compared to non-Hispanic whites, blacks had significantly lower rates of localized HCC at diagnosis (47.0% vs. 52.0%,p<0.01).On multivariate logistic regression, compared to non-Hispanic whites, blacks were significantly more likely to have advanced HCC at diagnosis (OR 1.20, 95% CI 1.10 -1.30, p<0.001), whereas Asians were less likely to have advanced disease (OR 0.87, 95% CI 0.80 -0.94, p<0.001).After adjusting for stage of disease, Asians were significantly more likely to receive any HCC treatment (OR 1.23, p<0.001), whereas Hispanics (OR 0.61, 95% CI 0.57-0.65,p<0.001) and blacks (OR 0.61, 95% CI 0.56-0.66,p<0.001) were significantly less likely to receive HCC treatment when compared to non-Hispanic whites.Conclusion: Despite having the highest HCC incidence among all race/ethnic groups, Asians were more likely to have localized HCC at time of diagnosis and were significantly more likely to receive HCC treatment.In contrast, blacks with HCC were significantly more likely to have advanced HCC at diagnosis and less likely to receive any HCC treatment.